No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
No Data
Cathie Wood-Led Ark Invest Scoops Up $5.16M Worth Of Palantir Shares Amid Raging AI Fervor
Recursion Pharmaceuticals(RXRX.US) Officer Sells US$43,290 in Common Stock
Insider Sale: Director Blake Borgeson Sells Shares of Recursion Pharmaceuticals Inc (RXRX)
Express News | Recursion Pharmaceuticals Inc : Leerink Partners Cuts Target Price to $9 From $10
Recursion Pharmaceuticals(RXRX.US) Director Sells US$108.81K in Common Stock
Recursion Pharmaceuticals Down Nearly 18%, on Pace for Largest Percent Decrease Since March 2022 -- Data Talk